Diagnostic Utility of Fractional Exhaled Nitric Oxide Findings in Patients of Asthma, COPD and Asthma and COPD Overlap

Authors

  • Yasmoon A. Siddiqui Senior Resident,Department of Respiratory Medicine, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly Uttar Pradesh, India
  • Rajeev Tandon Professor,Department of Respiratory Medicine, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly Uttar Pradesh, India
  • Lalit Singh Professor Department of Respiratory Medicine, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly Uttar Pradesh, India
  • Pradeep Nirala Assistant Professor Teerthanker Mahaveer Medical College and Research Centre, Moradabad, Uttar Pradesh, India

DOI:

https://doi.org/10.21761/jms.v7i02.09

Keywords:

Asthma, Fractional Exhaled Nitric Oxide, Chronic obstructive pulmonary disease

Abstract

Asthma, COPD and COOP Overlap Syndrome
are among the most prevalent chronic disorders affecting the
general population. The study was intended to understand the
diagnostic utility of Fractional Exhaled Nitric Oxide (FeNO)
testing in Asthma, COPD and Asthma COPD Overlap syndrome
patients.

Downloads

Download data is not yet available.

Published

19-04-2023

How to Cite

[1]
Y. A. Siddiqui, R. Tandon, L. Singh, and P. Nirala, “Diagnostic Utility of Fractional Exhaled Nitric Oxide Findings in Patients of Asthma, COPD and Asthma and COPD Overlap”, SRMsJMS, vol. 7, no. 02, pp. 85-88, Apr. 2023.

Issue

Vol. 7 No. 02 (2022): SRMS JOURNAL OF MEDICAL SCIENCE

Section

Research Articles

Most read articles by the same author(s)